News About: Pharm. Industry
Yuyu chairman wins award for promoting foreign investment
Yu Seung-pil, Chairman and CEO of YuYu Inc., won an award for his role in inducing foreign capital. He said that developing a strong pharmaceutical industry is a key issue in Korea. To this end, Battelle, Yuyu Inc., C...
Woman named head of Korean Pharmaceutical Medicine Society
The Korean Society of Pharmaceutical Medicine (KSPM) appointed Chi Dong-hyun, medical director and executive managing director of Abbott Korea, as its new president, the association announced recently.
The KSPM is ...
KPTA to boost pharmaceutical export
The Korea Pharmaceutical Traders Association unveiled its plan to open up new overseas markets next year, even amid business downturn around the world.
The KPTA will organize and dispatch trade missions and market ...
Korean drugmakers urged to develop first generic versions
In Korea, considered one of Asia's top pharmacy markets, the size is expected to go up 9 percent to almost 12 trillion won this year.
Along with the sizeable jump, the competition between local and global makers wi...
RMS Korea on bumpy road
RMS Korea plans to acquire financially distressed Inyoung Pharm at the end of this year to expand its presence in the domestic drug logistics market.
However, the company has been facing strong challenge from local...
8.7 billion won set aside against tuberculosis
The government will provide Green Cross Corporation with 8.7 billion to help produce BCG vaccine in Korea as part of its efforts to eradicate tuberculosis.
The Ministry of Health, Welfare and Family Affairs has an...
CJ-Henkel Korea team up over household insecticides
It is usual for the nation's two companies to have forged a partnership to strengthen their presence in the market.
CJ Cheil Jedang and Henkel Korea, Korean unit of Germany based Henkel AG, said on December 8 that...
Korea's pharmaceutical pricing system
The government intends not to cut the insurance price of an original drug if a generic product is not launched despite its listing in the eligible health insurance. However, any patent trial to confirm the scope of a ...
Pharmaceutical firms stalling on new plans
Reflecting increasing uncertainty in the global economy with protracted weakening of the won against the U.S. dollar and the Japanese yen, major Korean pharmaceutical manufacturers are delaying the formulation of thei...
AZK teams with Daewoong over NexiumIndustry watchers expect the domestic anti-ulcerant market is about to heat up, as AstraZeneca Korea (AZK) has joined hands with Daewoong Pharm to market Nexium (esomeprazole ma...
|
